NVCR ▲ +14.1% - NovoCure Limited $NVCR reported Q3 2026 EPS of -$0.09, beating the -$0.23 estimate by 60.9%. Revenue of $193.4M beat the $182.4M estimate by 6.0%. 29-OCT-2026 07:12 AM ET